Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium chloride; Calcium chloride dihydrate; Potassium chloride; Sodium lactate solution 60%
Laboratoire AGUETTANT
B05BB; B05BB01
Sodium chloride; Calcium chloride dihydrate; Potassium chloride; Sodium lactate solution 60%
Solution for infusion
Solutions affecting the electrolyte balance; electrolytes
Not marketed
2007-05-18
PACKAGE LEAFLET: INFORMATION FOR THE USER HARTMANN’S SOLUTION (Compound Sodium Lactate Intravenous Infusion B.P.) SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, SODIUM LACTATE 60% READ ALL OF THIS LEAFLET CAREFULLY BEFORE BEING GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Hartmann’s solution is and what it is used for 2. What you need to know before you are given Hartmann’s solution 3. How Hartmann’s solution is given 4. Possible side effects 5. How to store Hartmann’s solution 6. Contents of the pack and other information 1. WHAT HARTMANN’S SOLUTION IS AND WHAT IT IS USED FOR Hartmann’s solution is a clear solution of sodium chloride, potassium chloride, calcium chloride dihydrate and sodium lactate 60% in water. The solution is stored in a sealed plastic container. Sodium, potassium, calcium and chloride ions are important for maintaining the correct balance of fluid in and around the body’s cells and tissues and are involved in nerve signals and muscle contractions. Hartmann’s solution may be given for a variety of reasons: - to help restore fluid levels and the normal salt balance - to correct for low blood pressure or decreased blood volume - to treat metabolic acidosis, a condition where there is increased acid in the body. The solution may be given alone but may be given with other medicines added. You will be given Hartmann’s solution in hospital by a doctor or nurse. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN HARTMANN’S SOLUTION YOU MUST NOT BE GIVEN HARTMANN’S SOLUTION IF YOU HAVE: • increased levels of SODIUM , POTASSIUM , CALCIUM or CHLORIDE in the blood. These conditions can be detected in blood tests • severe KIDNEY DISEASE and you are pass Read the complete document
Health Products Regulatory Authority 17 July 2023 CRN00DKNQ Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hartmann's Solution Compound Sodium Lactate Intravenous Infusion BP 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1000 ml contains: Sodium Chloride 6.00 g Potassium Chloride 0.40 g Calcium Chloride dihydrate 0.27 g Sodium lactate 60% 5.16 g ionic formula Sodium (Na + ) 131 mmol/l Potassium (K + ) 5 mmol/l Calcium (Ca ++ ) 2 mmol/l Chloride (Cl - ) 111 mmol/l Bicarbonate (as Lactate) 29 mmol/l For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear colourless solution. Osmolarity: 278 mOsm/l (approx.) pH: 5.0 – 7.0 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ringer Lactate solution is indicated for: _-_ Restoration of extracellular fluid and electrolyte balances or replacement of extracellular fluid loss where isotonic concentrations of electrolytes are sufficient - Short term volume replacement (alone or in association with colloid) in case of hypovolemia or hypotension. - Regulation or maintenance of metabolic acidosis balance and/or treatment of mild to moderate metabolic acidosis (except lactic acidosis). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Recommended dosage:_ The amount of Compound Sodium Lactate solution (Ringer Lactate solution) needed to restore normal blood volume is 3 to 5 times the volume of lost blood. The recommended dosage is: - for adults: 500 ml to 3 litres / 24h - for paediatric patients: 20 ml to 100 ml/kg/24 h. Special clinical conditions, such as massive blood loss, burns, surgical drains, diarrhea, require additional adjustments of the necessary IV fluid volume. Health Products Regulatory Authority 17 July 2023 CRN00DKNQ Page 2 of 7 Fluid balance, serum electrolytes and acid-base balance may need to be monitored before and during administration, with particular attention to serum sodium in patients with increased non-osmotic vasopressin re Read the complete document